Trials / Completed
CompletedNCT03185546
Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors
Project 2: The Impact of Cigarette Nicotine Content, E-cigarette Nicotine Content, and E-cigarette Flavoring on Smoking Behavior
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 156 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Project 2 will evaluate the impact of very low nicotine content cigarettes, e-cigarette nicotine content, and e-cigarette flavoring on cigarettes smoked per day, nicotine exposure, puff topography, discomfort/dysfunction, other health-related behaviors, nicotine/tobacco dependence, biomarkers of tobacco exposure, intention to quit, compensatory smoking, other tobacco use, cardiovascular function, and perceived risk. Project 2 will also evaluate differences between conditions in compliance with product use and the ability to abstain from cigarette smoking when provided a financial incentive for abstinence from combusted tobacco. This is not a treatment program for smoking.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NNC Spectrum Cigarette | Participants are provided with normal nicotine content Spectrum Cigarette for 13 weeks. |
| OTHER | VLNC Spectrum Cigarette | Participants are provided with very low nicotine content Spectrum Cigarette for13 weeks |
| OTHER | Moderate nicotine level e-liquid | Participants are provided with moderate nicotine level e-liquid for 13 weeks |
| OTHER | Low nicotine level e-liquid | Participants are provided with very low or nicotine-free nicotine level e-liquid for 13 weeks |
| OTHER | Tobacco Flavors | Participants can choose e-liquid flavors from a selection of tobacco flavors |
| OTHER | Tobacco and non-tobacco e-liquid flavors | Participants can choose e-liquid flavors from a selection of flavors that includes tobacco and non-tobacco choices |
Timeline
- Start date
- 2018-08-06
- Primary completion
- 2020-03-13
- Completion
- 2020-03-13
- First posted
- 2017-06-14
- Last updated
- 2021-05-14
- Results posted
- 2021-05-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03185546. Inclusion in this directory is not an endorsement.